Literature DB >> 33521720

COVID-19 and fungal infection: the need for a strategic approach.

P Lewis White1, Rishi Dhillon1, Harriet Hughes1, Matthew P Wise1, Matthijs Backx2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33521720      PMCID： PMC7832937          DOI： 10.1016/S2666-5247(20)30127-0

Source DB:  PubMed          Journal:  Lancet Microbe        ISSN： 2666-5247


× No keyword cloud information.
  5 in total

1.  Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.

Authors:  Kieren A Marr; Michel Laverdiere; Anja Gugel; Wendy Leisenring
Journal:  Clin Infect Dis       Date:  2005-05-05       Impact factor: 9.079

2.  COVID-19 and fungal superinfection.

Authors:  Katie L Heard; Stephen Hughes; Nabeela Mughal; Luke S P Moore
Journal:  Lancet Microbe       Date:  2020-07-03

3.  Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis.

Authors:  Darius Armstrong-James; Jonathan Youngs; Tihana Bicanic; Alireza Abdolrasouli; David W Denning; Elizabeth Johnson; Varun Mehra; Tony Pagliuca; Brijesh Patel; Johanna Rhodes; Silke Schelenz; Anand Shah; Frank L van de Veerdonk; Paul E Verweij; P Lewis White; Matthew C Fisher
Journal:  Eur Respir J       Date:  2020-10-01       Impact factor: 16.671

4.  Invasive fungal diseases during COVID-19: We should be prepared.

Authors:  J-P Gangneux; M-E Bougnoux; E Dannaoui; M Cornet; J R Zahar
Journal:  J Mycol Med       Date:  2020-04-06       Impact factor: 2.391
  5 in total
  5 in total

1.  Schiff bases of sulphonamides as a new class of antifungal agent against multidrug-resistant Candida auris.

Authors:  Asad Hamad; Yiyuan Chen; Mohsin A Khan; Shirin Jamshidi; Naima Saeed; Melanie Clifford; Charlotte Hind; J Mark Sutton; Khondaker Miraz Rahman
Journal:  Microbiologyopen       Date:  2021-08       Impact factor: 3.139

2.  Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center.

Authors:  Sumit Mrig; Kabir Sardana; Pooja Arora; Vineet Narula; Sandeep Arora; Amrit Kapoor; Ritu Raj Baruah; Poornima Sen; Shweta Agarwal; Soumya Sachdeva; Arun Dewan; Sanjeet Panesar
Journal:  Am J Otolaryngol       Date:  2022-04-08       Impact factor: 2.873

Review 3.  Practice Guidelines for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis in an Intensive Care Setting.

Authors:  Zia Hashim; Zafar Neyaz; Rungmei S K Marak; Alok Nath; Soniya Nityanand; Naresh K Tripathy
Journal:  J Intensive Care Med       Date:  2021-10-22       Impact factor: 2.889

4.  Design, Synthesis and Antifungal Evaluation of Novel Pyrylium Salt In Vitro and In Vivo.

Authors:  Yue Zhang; Qiuhao Li; Wen Chao; Yulin Qin; Jiayan Chen; Yingwen Wang; Runhui Liu; Quanzhen Lv; Jinxin Wang
Journal:  Molecules       Date:  2022-07-12       Impact factor: 4.927

5.  Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.

Authors:  Tarjani Vivek Dave; Akshay Gopinathan Nair; Raghuraj Hegde; Nidhi Vithalani; Savari Desai; Namrata Adulkar; Saurabh Kamal; Raman Mittal; Renuka A Bradoo
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021 Sep-Oct 01       Impact factor: 2.011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.